NCT03488186View on ClinicalTrials.gov

PK-PD Comparative Study of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 19, 2018

Primary Completion Date

October 11, 2018

Study Completion Date

April 24, 2019

Conditions
Effect of DrugsSafety Issues
Interventions
DRUG

Lansoprazole Capsules

24 healthy volunteers will be recruited and randomized into 2 groups (12 for each). During the study session, subjects will receive T drug in group A or R drug in group B for 7 days in fasted condition.

Trial Locations (1)

310003

First affiliated hospital of Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Beijing Xuze Medical Technology Co., LTD.

OTHER

lead

First Affiliated Hospital of Zhejiang University

OTHER

NCT03488186 - PK-PD Comparative Study of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese Volunteers | Biotech Hunter | Biotech Hunter